Company
Every investor coverage indicates participated in a round University of Pennsylvania raised.
Companies University of Pennsylvania acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming University of Pennsylvania. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A profile of Chimeric Therapeutics and CEO Rebecca McQualter covering its CAR T cancer therapy, clinical progress, manufacturing partnerships, FDA designations, and path to Phase 2 trials by mid-2026.
Australian biotech ENA Respiratory raised funding led by Brandon Capital and Minderoo Foundation to advance its Covid-19 nasal spray toward the clinic, and appointed Ruth Tal-Singer to its board.